Literature DB >> 7935428

A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element.

D A Sukovich1, R Mukherjee, P A Benfield.   

Abstract

The estrogen receptor (ER) typically activates gene transcription by binding to estrogen-responsive elements (EREs). The brain creatine kinase (BCK) promoter is responsive to estrogen but contains no ERE-related sequence. To investigate the mechanism of estrogen induction, we have introduced the estrogen receptor into HeLa cells and primary rat cardiomyocytes and fibroblasts along with 195 bp of BCK promoter linked to a chloramphenicol acetyltransferase (CAT) reporter gene. A 10-fold stimulation of CAT activity was observed in the presence of beta-estradiol in both HeLa and rat primary fibroblasts, but no induction was observed in primary rat cardiomyocytes. In contrast, a control vitellogenin gene construct which contains a typical ERE was induced in an ER-dependent manner in all cell types studied. Estrogen induction in HeLa was not sensitive to cycloheximide and was blocked by the ER antagonists tamoxifen and ICI 164,384. Analysis of 5' deletion and linker-scanning mutations indicates sequences between bp -45 and -75 including a TA-rich sequence and a CCAAT sequence to be crucial for stimulation of the BCK promoter by the ER. BCK estrogen induction is dependent on the DNA-binding domain and transactivation domain TAF2 of the ER. However, direct DNA binding is probably not required. Taken together, these results suggest a novel mechanism for ER-mediated gene activation. This mechanism is consensus ERE independent and cell type specific and requires interactions between the ER and molecules capable of interacting with the BCK promoter TA-rich region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935428      PMCID: PMC359247          DOI: 10.1128/mcb.14.11.7134-7143.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Distinct classes of transcriptional activating domains function by different mechanisms.

Authors:  D Tasset; L Tora; C Fromental; E Scheer; P Chambon
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

2.  A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes.

Authors:  L A Gossett; D J Kelvin; E A Sternberg; E N Olson
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

Authors:  D M Ignar-Trowbridge; K G Nelson; M C Bidwell; S W Curtis; T F Washburn; J A McLachlan; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone.

Authors:  D Sömjen; Y Weisman; A Harell; E Berger; A M Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Brain and muscle creatine kinase genes contain common TA-rich recognition protein-binding regulatory elements.

Authors:  R A Horlick; G M Hobson; J H Patterson; M T Mitchell; P A Benfield
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response.

Authors:  K Iwaki; V P Sukhatme; H E Shubeita; K R Chien
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

7.  Two different RNA polymerase II initiation complexes can assemble on the rat brain creatine kinase promoter.

Authors:  M T Mitchell; P A Benfield
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

8.  The human estrogen receptor has two independent nonacidic transcriptional activation functions.

Authors:  L Tora; J White; C Brou; D Tasset; N Webster; E Scheer; P Chambon
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

9.  Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.

Authors:  M Berry; D Metzger; P Chambon
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

10.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.

Authors:  L Tora; A Mullick; D Metzger; M Ponglikitmongkol; I Park; P Chambon
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  17 in total

1.  Bip is a molecular link between the phase I and phase II estrogenic responses in uterus.

Authors:  Sanhita Ray; Xiaonan Hou; Han-E Zhou; Haibin Wang; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2006-03-30

2.  Repression by HoxA7 is mediated by the homeodomain and the modulatory action of its N-terminal-arm residues.

Authors:  C A Schnabel; C Abate-Shen
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

Review 3.  Molecular characterization of the creatine kinases and some historical perspectives.

Authors:  W Qin; Z Khuchua; J Cheng; J Boero; R M Payne; A W Strauss
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

Review 4.  Estrogen effects in the heart.

Authors:  T Pelzer; A Shamim; L Neyses
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

5.  Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.

Authors:  M Singh; G Sétáló; X Guan; D E Frail; C D Toran-Allerand
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

6.  Estradiol in females may negate skeletal muscle myostatin mRNA expression and serum myostatin propeptide levels after eccentric muscle contractions.

Authors:  Darryn S Willoughby; Colin D Wilborn
Journal:  J Sports Sci Med       Date:  2006-12-15       Impact factor: 2.988

7.  Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1.

Authors:  S C Power; S Cereghini
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

8.  RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.

Authors:  Jianfeng Chen; Yong Sun; Xia Mao; Qizhan Liu; Hui Wu; Yabing Chen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

9.  Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Authors:  D K Biswas; L Averboukh; S Sheng; K Martin; D S Ewaniuk; T F Jawde; F Wang; A B Pardee
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

10.  Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways.

Authors:  M Singh; G Sétáló; X Guan; M Warren; C D Toran-Allerand
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.